Clinical Trial Update: Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss [Phase 3]

View source ↗

Summary

Phase 3 clinical trial to determine the optimal time interval between mifepristone and misoprostol for treating early pregnancy loss; currently not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Mifepristone (mifepristone)

Snippet

Sponsor: University of Pennsylvania | Conditions: Early Pregnancy Loss | Phase 3 | Status: NOT_YET_RECRUITING